Genius Group stock rises after filing market manipulation lawsuit

Investing.com -- Deutsche Bank downgraded Azimut Holding (BIT:AZMT)to “hold” from “buy” after the Bank of Italy identified “significant gaps” in the governance and organization of Azimut Capital Management, a finding that is expected to slow the group’s TNB project, according to analyst Giovanni Razzoli, sending shares down over 2% on Monday.

The disclosure prompted a roughly 10% drop in Azimut’s stock, reflecting investor concern that the regulatory review will delay the initiative. 

Deutsche Bank said it now expects approval for the TNB project in the third or fourth quarter of 2026, about six months later than its previous forecast and a full year beyond Azimut’s July indication that approval could come by the end of 2025.

Management has said it still sees authorization arriving “by 2Q26, within the limits of common sense,” but Deutsche Bank described that as a best-case scenario. 

The projected delay also affects the expected timing of the initial €240 million payment from private equity firm FSI linked to the project, Deutsche Bank said.

Investing.com – Indonesia stocks were higher after the close on Monday, as gains in the Infrastructure, Financials and Agriculture sectors led shares higher.

At the close in Jakarta, the IDX Composite Index added 0.69% to hit a new all time high.

The best performers of the session on the IDX Composite Index were Apexindo Pratama Duta Tbk (JK:APEX), which rose 33.80% or 48.00 points to trade at 190.00 at the close. Meanwhile, Sanurhasta Mitra PT (JK:MINA) added 32.22% or 58.00 points to end at 238.00 and Sentral Mitra Informatika Tbk PT (JK:LUCK) was up 25.45% or 28.00 points to 138.00 in late trade.

The worst performers of the session were Sillo Maritime Perdana Tbk PT (JK:SHIP), which fell 14.86% or 1,025.00 points to trade at 5,875.00 at the close. Puri Global Sukses Tbk Pt (JK:PURI) declined 14.86% or 165.00 points to end at 945.00 and Estika Tata Tiara Tbk PT (JK:BEEF) was down 12.78% or 85.00 points to 580.00.

Rising stocks outnumbered declining ones on the Jakarta Stock Exchange by 355 to 324 and 175 ended unchanged.

Shares in Apexindo Pratama Duta Tbk (JK:APEX) rose to 52-week highs; gaining 33.80% or 48.00 to 190.00. Shares in Sentral Mitra Informatika Tbk PT (JK:LUCK) rose to 52-week highs; rising 25.45% or 28.00 to 138.00.

Crude oil for January delivery was down 0.58% or 0.35 to $59.60 a barrel. Elsewhere in commodities trading, Brent oil for delivery in January fell 0.54% or 0.35 to hit $64.04 a barrel, while the December Gold Futures contract fell 0.31% or 12.49 to trade at $4,081.71 a troy ounce.

USD/IDR was up 0.25% to 16,718.30, while AUD/IDR rose 0.10% to 10,919.76.

The US Dollar Index Futures was up 0.09% at 99.29.

Investing.com -- BiomX Inc. (NYSE American:PHGE) stock tumbled 14% in after-hours trading on Friday following the company’s announcement of a planned 1-for-19 reverse stock split.

The clinical-stage phage therapy developer said the reverse split will take effect on November 25, 2025, with the stock continuing to trade under the existing "PHGE" symbol on the NYSE American exchange. The move was previously approved by stockholders at the company’s annual meeting on October 16, with the final ratio determined by the Board of Directors on November 13.

Following the split, BiomX’s outstanding shares will be reduced from approximately 29 million to about 1.53 million. The company noted that the reverse split will not alter any stockholder’s percentage ownership interest, except for minor adjustments related to fractional shares, which will be rounded up to the next whole share.

The reverse split will also proportionally adjust shares underlying outstanding equity awards, warrants, and convertible preferred stock, as well as shares issuable under the company’s stock incentive plans. The par value of the common stock and the authorized number of shares will remain unchanged.

BiomX is developing phage therapies that target specific pathogenic bacteria. Continental Stock Transfer & Trust Company will handle the exchange process for stockholders who hold stock certificates, while those holding shares in book-entry form or brokerage accounts won’t need to take any action.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Repare Therapeutics Inc (NASDAQ:RPTX) stock surged 26% in after-hours trading Friday following the announcement of a definitive agreement to be acquired by XenoTherapeutics, a non-profit biotechnology company.

Under the terms of the deal, Repare shareholders will receive an estimated $1.82 per share in cash at closing, plus one non-transferable contingent value right (CVR) per common share. The CVRs entitle holders to receive future cash payments from the company’s existing partnerships with Bristol-Myers Squibb, Debiopharm, and DCx Biotherapeutics, as well as potential proceeds from licensing or disposition of Repare’s product candidates.

The transaction, which follows what the company described as a "thorough and wide-ranging strategic review," is expected to close in the first quarter of 2026, subject to shareholder and regulatory approvals. Following completion, Repare will become a privately held company and its shares will be delisted from the Nasdaq Global Select Market.

"The Transaction provides a cash payment to shareholders and the opportunity for continued participation in milestones and royalties from existing and potential future partnerships," said Steve Forte, President, Chief Executive Officer and Chief Financial Officer of Repare.

The Cambridge, Massachusetts-based precision oncology company also reported its third quarter 2025 financial results, posting revenue from collaboration agreements of $11.6 million compared to nil in the same period last year. Net income for the quarter was $3.3 million, or $0.08 per diluted share, a significant improvement from a net loss of $34.4 million, or $0.81 per share, in the third quarter of 2024.

Repare ended the quarter with $112.6 million in cash, cash equivalents, and marketable securities, up from $109.5 million at the end of the previous quarter.

The company recently presented positive initial data from its Phase 1 LIONS clinical trial for RP-1664, its first-in-class oral selective PLK4 inhibitor, at the 37th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com – U.S. stocks were mixed after the close on Friday, as gains in the Oil & Gas, Technology and Utilities sectors led shares higher while losses in the Basic Materials, Consumer Services and Financials sectors led shares lower.

At the close in NYSE, the Dow Jones Industrial Average fell 0.65%, while the S&P 500 index fell 0.05%, and the NASDAQ Composite index gained 0.13%.

The best performers of the session on the Dow Jones Industrial Average were NVIDIA Corporation (NASDAQ:NVDA), which rose 1.82% or 3.40 points to trade at 190.26 at the close. Meanwhile, Microsoft Corporation (NASDAQ:MSFT) added 1.41% or 7.09 points to end at 510.38 and Salesforce Inc (NYSE:CRM) was up 1.35% or 3.25 points to 243.68 in late trade.

The worst performers of the session were Unitedhealth Group (NYSE:UNH), which fell 3.22% or 10.72 points to trade at 321.80 at the close. Nike Inc (NYSE:NKE) declined 2.82% or 1.86 points to end at 64.17 and American Express Company (NYSE:AXP) was down 2.07% or 7.55 points to 357.18.

The top performers on the S&P 500 were Micron Technology Inc (NASDAQ:MU) which rose 4.17% to 246.83, Warner Bros Discovery Inc (NASDAQ:WBD) which was up 4.02% to settle at 23.03 and Super Micro Computer Inc (NASDAQ:SMCI) which gained 3.92% to close at 36.47.

The worst performers were Bristol-Myers Squibb Company (NYSE:BMY) which was down 4.07% to 46.65 in late trade, Eastman Chemical Company (NYSE:EMN) which lost 3.94% to settle at 60.25 and PayPal Holdings Inc (NASDAQ:PYPL) which was down 3.86% to 62.81 at the close.

The top performers on the NASDAQ Composite were Cidara Therapeutics Inc (NASDAQ:CDTX) which rose 105.41% to 217.71, Cypherpunk Technologies Inc (NASDAQ:CYPH) which was up 55.68% to settle at 2.74 and Cycurion Inc (NASDAQ:CYCU) which gained 51.44% to close at 6.33.

The worst performers were OneConstruction Group Ltd (NASDAQ:ONEG) which was down 49.42% to 5.19 in late trade, Nuvve Holding Corp (NASDAQ:NVVE) which lost 45.38% to settle at 0.26 and TSS Inc (NASDAQ:TSSI) which was down 43.34% to 8.64 at the close.

Falling stocks outnumbered advancing ones on the New York Stock Exchange by 1636 to 1104 and 96 ended unchanged; on the Nasdaq Stock Exchange, 1936 fell and 1443 advanced, while 155 ended unchanged.

Shares in Cidara Therapeutics Inc (NASDAQ:CDTX) rose to 5-year highs; rising 105.41% or 111.72 to 217.71.

The CBOE Volatility Index, which measures the implied volatility of S&P 500 options, was down 0.85% to 19.83.

Gold Futures for December delivery was down 2.61% or 109.44 to $4,085.06 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in December rose 2.22% or 1.30 to hit $59.99 a barrel, while the January Brent oil contract rose 2.06% or 1.30 to trade at $64.31 a barrel.

EUR/USD was unchanged 0.13% to 1.16, while USD/JPY rose 0.01% to 154.57.

The US Dollar Index Futures was up 0.11% at 99.16.

Investing.com – Colombia stocks were higher after the close on Friday, as gains in the Industrials, Services and Agriculture sectors led shares higher.

At the close in Colombia, the COLCAP gained 0.96%.

The best performers of the session on the COLCAP were Banco Davivienda Pf (BVC:DVI_p), which rose 2.08% or 600.00 points to trade at 29,500.00 at the close. Meanwhile, Grupo de Inversiones Suramericana SA (BVC:SIS) added 2.07% or 1,120.00 points to end at 55,100.00 and Grupo Argos SA Pref (BVC:ARG_p) was up 1.72% or 220.00 points to 13,040.00 in late trade.

The worst performers of the session were Canacol Energy Ltd (BVC:CNE), which fell 4.55% or 250.00 points to trade at 5,250.00 at the close. Grupo Nutresa SA (BVC:NCH) declined 4.14% or 10,900.00 points to end at 252,100.00 and Interconnection Electric SA ESP (BVC:ISA) was down 3.36% or 860.00 points to 24,720.00.

Falling stocks outnumbered advancing ones on the Colombia Stock Exchange by 0 to 0.

US coffee C for December delivery was down 0.21% or 0.85 to $400.85 . Elsewhere in commodities trading, US cocoa for delivery in December fell 4.26% or 234.00 to hit $5,253.00 , while the December Gold Futures contract fell 2.62% or 109.74 to trade at $4,084.76 a troy ounce.

USD/COP was up 0.07% to 3,756.75, while BRL/COP rose 0.11% to 709.49.

The US Dollar Index Futures was up 0.12% at 99.17.